Exosomal hsa_circ_0004658 demonstrated the ability to inhibit proliferation and migration while promoting apoptosis in HCC cells by targeting miR-499b-5p/JAM3 axis (112), which could function as a promising biomarker and therapeutic target for treating HCC. This evidence concerns the gene JAM3 and hepatocellular carcinoma.